Pioglitazone and Glimepiride on SilverScript Choice (S5601-060)
Covered.
Tier 4 (non-preferred drug). Quantity limit of 30 per 30 days.
$115.96
Patient pays / month, after deductible
$351.40
Patient pays / month, before the $615.00 deductible
$347.89
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
PIOGLITAZONE AND GLIMEPIRIDE 30/2 mg Tablet at a preferred retail pharmacy, from the plan's negotiated price of $351.40 for a month. Other covered strengths are listed below.
All 2 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| PIOGLITAZONE AND GLIMEPIRIDE 30/2 mg Tablet | 4 | $115.96 | 30 per 30 days |
| PIOGLITAZONE AND GLIMEPIRIDE 30/4 mg Tablet | 4 | $115.96 | 30 per 30 days |
Verify with the plan before prescribing or filling. Member services: (866)235-5660. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5601-060